ACHIEVEMENTS TO DATE

440 Publications
4 Major Textbooks
and 250 Research Extracts
presented at 80 National
and International meetings
Over 140 National and
International lectures

Publications and Presentations

I have published very extensively and widely in the general and renal journals. I have over 430 publications to date. My Hirsch “H” Index (2013) is 57, Google Scholar HI is 55, and My Research Gate metric (2016) is 48.43 (98% centile).

I have edited or authored four medical books. A Colour Handbook of Renal Medicine (Manson, London, 2004), the ABC of Kidney Disease (Wiley-Blackwell, Oxford, 2007; 2nd Edition 2013). Please click here for more information. Also, I was the senior editor for Cardio-renal Clinical Challenges (Eds Goldsmith, Spaak, Covic - Springer, London, 2014). Please click here for more information. I am one of the Senior Commissioning Editors (Eds Turner, Goldsmith, Himmelfarb, Lameire, Remuzzi, Winearls) of 4th Edition of the Oxford Textbook of Clinical Nephrology (OUP, Oxford, 2015). Please click here for more information. To view all four publications please click here.

I have undertaken over 140 national and international invited lectures at symposia and meetings, and also undertaken Visiting Professor programmes at the Karolinska Institutet Stockholm Sweden (2011), Amgen Visiting Professor (four kidney units in Australia, 2012) and most recently, Harvard and Bent Brigham Hospitals, Boston, USA (2015).

In addition to these, I have presented more than 250 research abstracts at over 80 national and international meetings from 1989 to the present day. I have given invited lectures to the American Society of Nephrology (2004, 2010, 2011, 2013, 2014 and 2015), National Kidney Federation (US), European Renal Association, UK Renal Association, British Renal Society, Romanian Society of Nephrology, Greek Society of Nephrology, Turkish Society of Nephrology, Israeli Society of Hypertension and Nephrology, Lebanese Society of Hypertension and Nephrology, Saudi Society of Nephrology, Phillipines Society of Nephrology, Society of Italian Nephrologists, Finnish Society of Nephrology, the Verband Deutsche Nierenzentren, the Dutch Transplantation Society, the Japanese Society of Dialysis and Transplantation, and participated in over 100 other postgraduate nephrology courses in the UK and the rest of the World.

Below is a list of the main publications, from 1989 - Present)



pro-david-gold
Publications and Presentations 2015

Eriksson D, Teitsson S, Goldsmith D, Jackson J, van Nooten FE. Cross-Sectional
Descriptive Study Of The Impact Of Anaemia In Patients With Chronic Kidney Disease On Healthcare Resource Utilisation And Work Productivity Across Europe.
Value Health. 2015 Nov;18(7):A514. doi: 10.1016/j.jval.2015.09.1489.
Epub 2015Oct 20. PubMed PMID: 26532882.

Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D; ERA-EDTA EURECA-m working group; Red de Investigación Renal (REDINREN) network; Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network.
The double challenge of resistant hypertension and chronic kidney disease.
Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3.
Review. PubMed PMID: 26530623.

Montero RM, Covic A, Gnudi L, Goldsmith D.
Diabetic nephropathy: What does the future hold?
Int Urol Nephrol. 2016 Jan;48(1):99-113. doi:10.1007/s11255-015-1121-y.
Epub 2015 Oct 5. PubMed PMID: 26438328.

Afsar B, Ortiz A, Covic A, Gaipov A, Esen T, Goldsmith D, Kanbay M.
Phosphodiesterase type 5 inhibitors and kidney disease.
Int Urol Nephrol. 2015 Sep;47(9):1521-8. doi: 10.1007/s11255-015-1071-4.
Epub 2015 Aug 5. PubMed PMID:26242375.

Greenwood SA, Koufaki P, Mercer TH, Rush R, O'Connor E, Tuffnell R, Lindup H, Haggis L, Dew T, Abdulnassir L, Nugent E, Goldsmith D, Macdougall IC.
Aerobic or Resistance Training and Pulse Wave Velocity in Kidney Transplant Recipients: A 12-Week Pilot Randomized Controlled Trial (the Exercise in Renal Transplant
[ExeRT] Trial). Am J Kidney Dis. 2015 Oct;66(4):689-98. doi: 10.1053/j.ajkd.2015.06.016.
Epub 2015 Jul 22. PubMed PMID: 26209542.

Sinha MD, Turner C, Booth CJ, Waller S, Rasmussen P, Goldsmith DJ, Simpson JM.
Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease. Pediatr Nephrol.
2015 Oct;30(10):1843-52. doi: 10.1007/s00467-015-3125-3.
Epub 2015 May 15. PubMedPMID: 25975437.

Guideline development group.
Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher
(eGFR 45mL/min). Nephrol Dial Transplant. 2015 May;30 Suppl 2:ii1-142.
doi: 10.1093/ndt/gfv100. PubMed PMID: 25940656.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876.
Epub 2015 Jun 9. PubMed PMID: 26059012.

Goldsmith D, Covic A, Vervloet M, Cozzolino M, Nistor I; Chronic Kidney Disease-Mineral
Bone Disease (CKD-MBD) working group and the European Renal Best Practice (ERBP) advisory board; Chronic Kidney Disease-Mineral Bone Disease CKD-MBD working group and the European Renal Best Practice ERBP advisory board.
Should patients with CKD stage 5D and biochemical evidence of secondary
hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position
statement.

Nephrol Dial Transplant. 2015 May;30(5):698-700. doi: 10.1093/ndt/gfv050.
Epub 2015 Mar 4. PubMed PMID: 25928337.

Fernández-Martín JL, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Gorriz JL, Rutkowski B, Ferreira A, Bos WJ, Covic A,Rodríguez-García M, Sánchez JE, Rodríguez-Puyol D, Cannata-Andia JB; COSMOS group.
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
Nephrol DialTransplant. 2015 Sep;30(9):1542-51. doi: 10.1093/ndt/gfv099.
Epub 2015 Apr 28. PubMed PMID: 25920921.

Gesualdo L, Combe C, Covic A, Dellanna F, Goldsmith D, London G, Mann JF,
Zaoui P, Turner M, Muenzberg M, MacDonald K, Abraham I.
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study).
Int Urol Nephrol. 2015 May;47(5):837-45. doi: 10.1007/s11255-015-0970-8.
Epub 2015 Apr 17. PubMed PMID: 25894959; PubMed Central PMCID: PMC4555197.

McIntyre CW, Goldsmith DJ.
Ischemic brain injury in hemodialysis patients: which is more dangerous,
hypertension or intradialytic hypotension? Kidney Int.

2015 Jun;87(6):1109-15. doi: 10.1038/ki.2015.62.
Epub 2015 Apr 8. Review. PubMed PMID: 25853331.

Covic A, Goldsmith D, Donciu MD, Siriopol D, Popa R, Kanbay M, London G.
From Profusion to Confusion: The Saga of Managing Hypertension in Chronic Kidney Disease!
J Clin Hypertens (Greenwich). 2015 Jun;17(6):421-7. doi: 10.1111/jch.12508.
Epub 2015 Feb 28. PubMed PMID: 25727490.

Charytan DM, Fishbane S, Malyszko J, McCullough PA, Goldsmith D.
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.
Am J Kidney Dis. 2015 Aug;66(2):196-205. doi: 10.1053/j.ajkd.2014.12.016.
Epub 2015 Feb 26. Review. PubMed PMID: 25727384; PubMed Central PMCID: PMC4516683.

Bover J, Evenepoel P, Ureña-Torres P, Vervloet MG, Brandenburg V, Mazzaferro
S, Covic A, Goldsmith D, Massy ZA, Cozzolino M; CKD-MBD Working Group of
ERA-EDTA.
Opponent's comments.
Nephrol Dial Transplant. 2015 Mar;30(3):357. doi: 10.1093/ndt/gfv021a.
PubMed PMID: 25712937.

Bover J, Evenepoel P, Ureña-Torres P, Vervloet MG, Brandenburg V, Mazzaferro
S, Covic A, Goldsmith D, Massy ZA, Cozzolino M; CKD-MBD Working Group of
ERA-EDTA.
Pro: Cardiovascular calcifications are clinically relevant.
Nephrol Dial Transplant. 2015 Mar;30(3):345-51. doi: 10.1093/ndt/gfv020.
PubMed PMID: 25712934.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM;
Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE)
Trial Investigators. The Effects of Cinacalcet in Older and Younger Patients on
Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular
Events (EVOLVE) Trial.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814.
Epub 2015 Feb 20. PubMed PMID: 25710802; PubMed Central PMCID: PMC4422239.

Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, Mehrotra A,
Mitsnefes MM, Sica DA, Taler SJ.
Assessment and management of hypertension intransplant patients.
J Am Soc Nephrol. 2015 Jun;26(6):1248-60. doi: 10.1681/ASN.2014080834.
Epub 2015 Feb 4. Review. PubMed PMID: 25653099; PubMed Central PMCID: PMC4446882.

Shavit L, Girfoglio D, Vijay V, Goldsmith D, Ferraro PM, Moochhala SH, Unwin R.
Vascular calcification and bone mineral density in recurrent kidney stone formers.
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):278-85. doi: 10.2215/CJN.06030614.
Epub 2015 Jan 29. PubMed PMID: 25635036; PubMed Central PMCID: PMC4317743.

Tamburrini R, Ahmed Z, van der Walt J, Goldsmith D.
Sudden death of a patient with polycystic kidneys due to acute inferior vena cava thrombosis.
Scott Med J. 2015 Jan 28. pii: 0036933014567050.
[Epub ahead of print] PubMed PMID: 25634914.

Humalda JK, Goldsmith DJ, Thadhani R, de Borst MH.
Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.
Nephrol Dial Transplant. 2015 Dec;30(12):1988-94. doi: 10.1093/ndt/gfu404.
Epub 2015 Jan 20. Review. PubMed PMID: 25609737.

Bhuvanakrishna T, Blake GM, Hilton R, Burnapp L, Sibley-Allen C, Goldsmith D.
Comparison of estimated GFR and measured GFR in prospective living kidney donors.
Int Urol Nephrol. 2015 Jan;47(1):201-8. doi: 10.1007/s11255-014-0859-y.
Epub 2014 Nov 6. PubMed PMID: 25374260.

Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O, Van Biesen W;
European Renal Best Practice (ERBP) Diabetes Guideline Development Group.
Dialysis modality choice in diabetic patients with end-stage kidney disease: a
systematic review of the available evidence.

Nephrol Dial Transplant. 2015 Feb;30(2):310-20. doi: 10.1093/ndt/gfu293.
Epub 2014 Sep 23. Review. PubMed PMID: 25248364.

Publications and Presentations 2014

Shavit L, Girfoglio D, Vijay V, Goldsmith D, Ferraro PM, Moochhala SH, Unwin R.
Vascular calcification and bone mineral density in recurrent kidney stone formers.
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):278-85. doi: 10.2215/CJN.06030614.
Epub 2015 Jan 29. PubMed PMID: 25635036; PubMed Central PMCID: PMC4317743.

Goldsmith DJ, Massy ZA, Brandenburg V.
The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
Semin Nephrol. 2014 Nov;34(6):660-8. doi: 10.1016/j.semnephrol.2014.10.002. Review.
PubMed PMID: 25498384.

Bover J, Ureña P, Brandenburg V, Goldsmith D, Ruiz C, DaSilva I, Bosch RJ.
Adynamic bone disease: from bone to vessels in chronic kidney disease.
Semin Nephrol. 2014 Nov;34(6):626-40. doi: 10.1016/j.semnephrol.2014.09.008. Review.
PubMed PMID: 25498381.

Mazzaferro S, Tartaglione L, Rotondi S, Bover J, Goldsmith D, Pasquali M.
News on biomarkers in CKD-MBD.
Semin Nephrol. 2014 Nov;34(6):598-611. doi: 10.1016/j.semnephrol.2014.09.006. PubMed PMID: 25498379.

Covic A, Voroneanu L, Goldsmith D. Routine
Bioimpedance-derived volume assessment for all hypertensives: a new paradigm.
Am J Nephrol. 2014;40(5):434-40. doi: 10.1159/000369218.
Epub 2014 Nov 22. PubMed PMID: 25427586.

Bhuvanakrishna T, Blake GM, Hilton R, Burnapp L, Sibley-Allen C, Goldsmith D.
Comparison of estimated GFR and measured GFR in prospective living kidney donors.
Int Urol Nephrol. 2015 Jan;47(1):201-8. doi: 10.1007/s11255-014-0859-y.
Epub 2014 Nov 6. PubMed PMID: 25374260.

Covic A, Nistor I, Donciu MD, Dumea R, Bolignano D, Goldsmith D.
Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic
kidney disease: a meta-analysis of 19 studies.

Am J Nephrol. 2014;40(3):263-79.doi: 10.1159/000366025.
Epub 2014 Oct 15. Review. PubMed PMID: 25323019.

Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O, Van Biesen W; European Renal Best Practice (ERBP) Diabetes Guideline Development Group.
Dialysis modality choice in diabetic patients with end-stage kidney disease: a
systematic review of the available evidence.

Nephrol Dial Transplant. 2015 Feb;30(2):310-20. doi: 10.1093/ndt/gfu293.
Epub 2014 Sep 23. Review. PubMed PMID: 25248364.

Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H, Karaman M, Unal HU, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Yilmaz MI.
Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease
patients.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1854-61. doi: 10.1210/jc.2014-2042.
Epub 2014 Jul 24. PubMed PMID: 25057883.

Goldsmith D, Covic A.
Oral phosphate binders in CKD - is calcium the (only) answer?
Clin Nephrol. 2014 Jun;81(6):389-95. Review. PubMed PMID: 25017668.

Kassimatis TI, Goldsmith DJ.
Statins in chronic kidney disease and kidney transplantation.
Pharmacol Res. 2014 Oct;88:62-73. doi: 10.1016/j.phrs.2014.06.011.
Epub 2014 Jul 1. Review. PubMed PMID: 24995940.

Patel KH, Goldsmith DJ.
Uric acid as a cardiorenal risk factor - ready for prime-time?
Int J Clin Pract. 2014 Jul;68(7):796-801. doi: 10.1111/ijcp.12428. PubMed PMID: 24942307.

Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM; Board of the EURECA-m Working Group of ERA-EDTA.
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.
Lancet. 2014 May 24;383(9931):1831-43. doi: 10.1016/S0140-6736(14)60384-6. Review. PubMed PMID: 24856028.

Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, Karaman M, Oguz Y, Eyileten T, Vural A, Covic A, Goldsmith D, Turak O, Yilmaz MI.
Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.
Int Urol Nephrol. 2014 Aug;46(8):1619-25. doi: 10.1007/s11255-014-0730-1.
Epub 2014 May 23. PubMed PMID: 24853998.

McGregor R, Li G, Penny H, Lombardi G, Afzali B, Goldsmith DJ.
Vitamin D in renal transplantation - from biological mechanisms to clinical benefits.
Am J Transplant. 2014 Jun;14(6):1259-70. doi: 10.1111/ajt.12738.
Epub 2014 May 19. Review. PubMed PMID: 24840071; PubMed Central PMCID: PMC4441280.

Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D; CKD-MBD Working Group of ERA-EDTA.
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.
Lancet Diabetes Endocrinol. 2014 May;2(5):427-36. doi: 10.1016/S2213-8587(14)70059-2. Review. PubMed PMID: 24795256.

JBS3 Board.
Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3).
Heart. 2014 Apr;100 Suppl 2:ii1-ii67. doi: 10.1136/heartjnl-2014-305693. Review. PubMed PMID: 24667225.

Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D.
Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients.
PLoS One. 2014 Mar 19;9(3):e91363. doi: 10.1371/journal.pone.0091363.
eCollection 2014. PubMed PMID: 24646518; PubMed Central PMCID: PMC3960127.

Goldsmith D, Covic A.
The EVOLVE study is negative, so what does this 'bitter pill' of disappointment mean now for renal patients?
Int J Clin Pract. 2014 Mar;68(3):286-9. doi: 10.1111/ijcp.12261. PubMed PMID: 24588948.

Hajhosseiny R, Khavandi K, Jivraj N, Mashayekhi S, Goldsmith DJ, Malik RA.
Have we reached the limits for the treatment of diabetic nephropathy? Expert Opin Investig Drugs.
2014 Apr;23(4):511-22. doi: 10.1517/13543784.2014.892580.
Epub 2014 Feb 21. Review. PubMed PMID: 24555907.

Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S; CKD-MBD Working Group of ERA-EDTA.
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514.
Epub 2014 Feb 9. PubMed PMID: 24516228.

Cozzolino M, Ketteler M, Martin KJ, Sharma A, Goldsmith D, Khan S.
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
Nephrol Dial Transplant. 2014 Apr;29(4):899-905. doi: 10.1093/ndt/gfu011.
Epub 2014 Feb 4. PubMed PMID: 24500308.

Al Rukhaimi M, Al Sahow A, Boobes Y, Goldsmith D, Khabouth J, El Baz T, Mahmoud H, Ganji MR, Shaheen FA;
Kidney Disease: Improving Global Outcomes. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
Saudi J Kidney Dis Transpl. 2014 Jan;25(1):133-48. Review. PubMed PMID: 24434398.

Goldsmith D, Nimmo C.
Reply to Jolobe.
Am Heart J. 2014 Jan;167(1):e3. doi: 10.1016/j.ahj.2013.10.015.
Epub 2013 Oct 23. PubMed PMID: 24332153.

Boutouyrie P, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, Martinez-Castelao A, Lindholm B, Massy ZA, Suleymanlar G, Sicari R, Gargani L, Parati G, Mallamaci F, Zoccali C, London GM.
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry.
Nephrol Dial Transplant. 2014 Feb;29(2):232-9. doi: 10.1093/ndt/gft309.
Epub 2013 Sep 30. Review. PubMed PMID: 24084326.

Liabeuf S, Okazaki H, Desjardins L, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, Martinez-Castelao A, Lindholm B, Suleymanlar G, Mallamaci F, Zoccali C, London G, Massy ZA.
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Nephrol Dial Transplant. 2014 Jul;29(7):1275-84. doi: 10.1093/ndt/gft368.
Epub 2013 Sep 5. Review. PubMed PMID: 24009287.

Leckstroem DC, Bhuvanakrishna T, McGrath A, Goldsmith DJ.
Prevalence and predictors of abdominal aortic calcification in healthy living kidney donors.
Int Urol Nephrol. 2014 Jan;46(1):63-70. doi: 10.1007/s11255-013-0485-0.
Epub 2013 Jun 20. PubMed PMID: 23783567.

Mazzaferro S, Goldsmith D, Larsson TE, Massy ZA, Cozzolino M.
Vitamin D metabolites and/or analogs: which D for which patient?
Curr Vasc Pharmacol. 2014 Mar;12(2):339-49. Review. PubMed PMID: 23713876.

Khavandi K, Brownrigg J, Hankir M, Sood H, Younis N, Worth J, Greenstein A,
Soran H, Wierzbicki A, Goldsmith DJ.
Interrupting the natural history of diabetes mellitus: lifestyle, pharmacological and surgical strategies targeting disease progression.
Curr Vasc Pharmacol. 2014 Jan;12(1):155-67. Review. PubMed PMID: 22272898.

Eriksson D, Teitsson S, Goldsmith D, Jackson J, van Nooten FE.
Cross-Sectional Descriptive Study Of The Impact Of Anaemia In Patients With Chronic Kidney Disease On Healthcare Resource Utilisation And Work Productivity Across Europe.
Value Health. 2015 Nov;18(7):A514. doi: 10.1016/j.jval.2015.09.1489.
Epub 2015Oct 20. Pub Med PMID: 26532882.

Hajhosseiny R, Khavandi K, Goldsmith DJA
Have we reached the limits for the treatment of diabetic nephropathy?
Expert opinion on investigational drugs, In Press, 2014

Vervloet MG, Massy ZA, Brandenburg V, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D.
Bone: A novel endocrine organ at the heart of chronic kidney disease – mineral and bone disorder
Lancet Diabetes and Endocrinology, In Press, 2014

Ortiz A, Fliser D, Covic A, Foque D, Goldsmith D, Kanbay M, Mallamaci F, Massy Z, Rossignol P.
Epidemiology, contributors and clinical trials targeting the unacceptably high mortality rates of chronic kidney failure (glomerular filtration rate (15 ml/min/1.72m2)
Lancet, In Press, 2014

Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D
Impact of Vitamin D supplementation on Arterial Vasomotion, Stiffness and Endothelial biomarkers in Chronic Kidney Disease Patients
PLOS ONE, In Press, 2014

Leckstroem DCT, Salzer J, Goldsmith DJA.
The trials and tribulations of vitamin D - time for the “sunshine” vitamin to come out of the cold - or just more broken promises?
Expert Review of Endocrinology and Metabolism, In Press, 2014

Li G, McGregor R, Penny H, Lombardi G, Afzali B, Goldsmith DJA
Vitamin D in renal transplantation – from biological mechanisms to clinical benefits
American Journal of Transplantation, In Press, 2014

Publications and Presentations 2013

Scully P, Goldsmith D.
The management of end-stage heart failure and reducing the risk of cardiorenal syndrome.
Clin Med. 2013 Dec;13(6):610-3.

de Wit KL, White BE, Goldsmith D.
Thiopurine toxicity.
Br J Hosp Med (Lond).2013 Oct;74(10):C153-6.

Boutouyrie P, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, Martinez-Castelao A, Lindholm B, Massy ZA, Suleymanlar G, Sicari R, Gargani L, Parati G, Mallamaci F, Zoccali C, London GM.
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry.
Nephrol Dial Transplant. 2014 Feb;29(2):232-9.

Liabeuf S, Okazaki H, Desjardins L, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, Martinez-Castelao A, Lindholm B, Suleymanlar G, Mallamaci F, Zoccali C, London G, Massy ZA.
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Nephrol Dial Transplant. 2013 Sep 5.

Cabezas-Rodriguez I, Carrero JJ, Zoccali C, Qureshi AR, Ketteler M, Floege J, London G, Locatelli F, Gorriz JL, Rutkowski B, Memmos D, Ferreira A, Covic A, Teplan V, Bos WJ, Kramar R, Pavlovic D, Goldsmith D, Nagy J, Benedik M, Verbeelen D, Tielemans C, Wüthrich RP, Martin PY, Martínez-Salgado C, Fernández-Martín JL, Cannata-Andia JB
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients.
Clin J Am Soc Nephrol. 2013 Oct;8(10):1725-33.

Frost ML, Compston JE, Goldsmith D, Moore AE, Blake GM, Siddique M, Skingle L, Fogelman I.
(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.
Calcif Tissue Int. 2013 Nov;93(5):436-47.

Salzer J, Goldsmith D.
Maternal vitamin D status during pregnancy and bone-mineral content in offspring.
Lancet. 2013 Aug 31;382(9894):766-7.

de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ.
Active vitamin D treatment for reduction of residual proteinuria: a systematic review.
J Am Soc Nephrol. 2013 Nov;24(11):1863-71.

Nimmo C, Wright M, Goldsmith D.
Management of atrial fibrillation in chronic kidney disease: double trouble.
Am Heart J. 2013 Aug;166(2):230-9.

O’Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G.
The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
Clin Biochem. 2013 Oct;46(15):1405-9.

Cannata-Andía JB, Fernández-Martín JL, Locatelli F, London G, Gorriz JL, Floege J, Ketteler M, Ferreira A, Covic A, Rutkowski B, Memmos D, Bos WJ, Teplan V, Nagy J, Tielemans C, Verbeelen D, Goldsmith D, Kramar R, Martin PY, Wüthrich RP, Pavlovic D, Benedik M, Sánchez JE, Martínez-Camblor P, Naves-Díaz M, Carrero JJ, Zoccali C.
Use of phosphate-binding agents is associated with a lower risk of mortality.
Kidney Int. 2013 Nov;84(5):998-1008.

Leckstroem DC, Bhuvanakrishna T, McGrath A, Goldsmith DJ.
Prevalence and predictors of abdominal aortic calcification in healthy living kidney donors.
Urol Nephrol. 2014 Jan;46(1):63-70.

Hajhosseiny R, Rajani R, Khavandi K, Sebag FA, Mashayekhi S, Wright M, Goldsmith D.
The prevalence of electrocardiographic early repolarization in an adult cohort with chronic kidney disease and its impact upon all-cause mortality and progression to dialysis.
Front Physiol. 2013 May 31;4:127.

Scully P, Leckstroem DC, McGrath A, Chambers J, Goldsmith DJ.
Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome.
Int Med Case Rep J. 2013 Jan 20;6:7-12.

Mazzaferro S, Goldsmith D, Larsson TE, Massy ZA, Cozzolino M. Vitamin D
Metabolites and/or Analogs: Which D for Which Patient?
Curr Vasc Pharmacol. 2013 May 16.

Goldsmith DJ, Lamb EJ.
Cinacalcet for cardiovascular disease in patients undergoing dialysis.
N Engl J Med. 2013 May 9;368(19):1843.

Sinha MD, Turner C, Goldsmith DJ.
FGF23 concentrations measured using “intact” assays similar but not interchangeable.
Int Urol Nephrol. 2013 Dec;45(6):1821-3.

Sardiwal S, Magnusson P, Goldsmith DJ, Lamb EJ.
Bone alkaline phosphatase in CKD-mineral bone disorder.
Am J Kidney Dis. 2013 Oct;62(4):810-22.

HLocatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Hörl W, London G, Vanholder R, Van Biesen W; ERA-EDTA ERBP Advisory Board.
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.
Nephrol Dial Transplant. 2013 Jun;28(6):1346-59.

Blake GM, Sibley-Allen C, Hilton R, Burnapp L, Moghul MR, Goldsmith D. Glomerular filtration rate in prospective living kidney donors.
Glomerular filtration rate in prospective living kidney donors.
Int Urol Nephrol. 2013 Oct;45(5):1445-52.

Dmitrieva O, de Lusignan S, Macdougall IC, Gallagher H, Tomson C, Harris K, Desombre T, Goldsmith D.
Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data.
BMC Nephrol. 2013 Jan 25;14:24.

Voong K, Harrington D, Goldsmith D.
Vitamin K status in chronic kidney disease: a report of a study and a mini-review.
Int Urol Nephrol. 2013 Oct;45(5):1339-44.

Fernández-Martín JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, Floege J, Goldsmith D, Gorriz JL, Ketteler M, Kramar R, Locatelli F, London G, Martin PY, Memmos D, Nagy J, Naves-Díaz M, Pavlovic D, Rodríguez-García M, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wüthrich RP, Martínez-Camblor P, Cabezas-Rodriguez I, Sánchez-Alvarez JE, Cannata-Andia JB.
COSMOS: the dialysis scenario of CKD-MBD in Europe.
Nephrol Dial Transplant. 2013 Jul;28(7):1922-35

Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Gargani L, Mallamaci F, London G, Zoccali C.
Pulmonary hypertension in CKD.
Am J Kidney Dis. 2013 Apr;61(4):612-22.

Goldsmith DJ.
Rebuttal: the case for routine parathyroid hormone monitoring.
Clin J Am Soc Nephrol. 2013 Feb;8(2):319-20.

Leonard O, Spaak J, Goldsmith D.
Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.
Br J Clin Pharmacol. 2013 Oct;76(4):560-72.

Penny H, Leckström D, Goldsmith D.
The Janus faces of ESAs: caveat Chimaera!
Int Urol Nephrol. 2013 Jun;45(3):761-7.

Sicari R, Gargani L, Wiecek A, Covic A, Goldsmith D, Suleymanlar G, Parati G, Ortiz A, Massy Z, Martinez-Castelao A, Lindholm B, Heine GH, Fliser D, Mallamaci F, London G, Zoccali C
EUropean REnal and Cardiovascular Medicine (EURECA-m) working group of European Renal Association-European Dialysis Transplantation Association (ERA-EDTA). The use of echocardiography in observational clinical trials: the EURECA-m registry.
Nephrol Dial Transplant. 2013 Jan;28(1):19-23.

Hajhosseiny R, Khavandi K, Goldsmith DJ.
Cardiovascular disease in chronic kidney disease: untying the Gordian knot.
Int J Clin Pract. 2013 Jan;67(1):14-31.

Gesualdo L, London G, Turner M, Lee C, Macdonald K, Goldsmith D, Covic A, Zaoui P, Combe C, Mann J, Dellanna F, Muenzberg M, Abraham I.
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.
Intern Emerg Med. 2013 Aug;8(5):389-99.

Hajhosseiny R, Rajani R, Khavandi K, Sebag FA, Mashayekhi S, Wright M, Goldsmith D.
The prevalence of electrocardiographic early repolarization in an adult cohort with chronic kidney disease and its impact upon all-cause mortality and progression to dialysis.
Front Physiol. 2013 May 31;4:127.

Scully P, Leckstroem D, Mcgrath A, Chambers J, Goldsmith DJA.
Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome.
International Medical Case Reports Journal 2013: 6:7-12

Saxena S, Sadideen H, Goldsmith D.
Treating stones in transplanted kidneys.
Minerva Med. 2013 Feb;104(1):31-40.

Garrett G, Sardiwal S, Lamb EJ, Goldsmith DJ.
PTH--A Particularly Tricky Hormone: Why Measure It at All in Kidney Patients?
Clin J Am Soc Nephrol. 2013 Feb;8(2):299-312.

Publications and Presentations 2012

Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A,Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Gargani L, Mallamaci F, London G, Zoccali C.
Pulmonary Hypertension in CKD.
Am J Kidney Dis. 2012 Nov 16. doi:pii: S0272-6386(12)01262-0.10.1053/j.ajkd.2012.07.029.

Bennett CL, Spiegel DM, Macdougall IC, Norris L, Qureshi ZP, Sartor O, Lai SY,Tallman MS, Raisch DW, Smith SW, Silver S, Murday AS, Armitage JO, Goldsmith D.
A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report fromthe Southern Network on Adverse Reactions (SONAR).
Semin Thromb Hemost. 2012 Nov;38(8):783-96.

Leonard O, Spaak J, Goldsmith D.
Regression of Vascular Calcification inChronic Kidney Disease - Feasible or Fantasy - a review of the clinical evidence.
Br J Clin Pharmacol. 2012 Oct 30. doi: 10.1111/bcp.12014.

Goldsmith D.
A new approach to authorship: institutions must decide.
J R Soc Med. 2012 Dec;105(12):50

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
N Engl J Med. 2012 Dec 27;367(26):2482-94.

Ketteler M, Martin KJ, Wolf M, Amdahl M, Cozzolino M, Goldsmith D, Sharma A, Marx S, Khan S.
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
Nephrol Dial Transplant. 2012 Aug;27(8):3270-8.

Ketteler M, Martin KJ, Cozzolino M, Goldsmith D, Sharma A, Khan S, Dumas E, Amdahl M, Marx S, Audhya P.
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: Results of the IMPACT SHPT study.
Nephrology Dialysis Transplantation, In Press, 2012

Khavandi K, Brownrigg J, Hankir M, Sood H, Younis N, Worth J, Greenstein A, Soran H, Wierzbicki A, Goldsmith DJ
Interrupting the Natural History of Diabetes Mellitus: Lifestyle, Pharmacological and Surgical Strategies Targeting Disease Progression.
Curr Vasc Pharmacol 2012 Jan 20

Macdougall IC, Roger SD, de Francisco A, Goldsmith DJ, Schellekens H, Ebbers H, Jelkmann W, London G, Casadevall N, Hörl WH, Kemeny DM, Pollock C.
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.
Kidney Int. 2012 Feb 15.

Heymann EP, Goldsmith D
What are the best approaches in the battle against Globesity [Global-Obesity] ? Learning lessons from our experience tackling HIV-AIDS and tobacco smoking
Journal of the Royal Society of Medicine, In Press, 2012

Zoccali C, Ortiz A, Massy Z, Lindholm B, Andrzej W, Castelao AM, Covic A, Goldsmith D, Suleymanlar G, London G, Parati G, Sicari R, Heine G, Fliser D
Monocyte subpopulations and cardiovascular risk in chronic kidney disease
Nature Reviews Nephrology, In Press, 2012

Jenkins M, Goldsmith DJA
Statins and Kidney Disease: Is SHARP at the cutting edge of evidence ?
Current Opinions in Cardiology, In Press, 2012

Garrett G, Sardiwal, S, Lamb E, Goldsmith DJA
PTH - A Particularly Tricky Hormone - why measure it all in chronic kidney disease patients ?
Clinical Journal of the American Society of Nephrology, In Press, April 2012

Garrett G, Goldsmith DJA
PTH measurements, Guidelines Statements,and Clinical Treatments – a real-world cautionary tale
Journal of Biological Chemistry, In Press 2012

Publications and Presentations 2011

Heymann EP, Goldsmith D.
The battle against obesity: lessons from tobacco.
Lancet. 2011 Dec 17;378(9809):2069.

Covic A, Apetrii M, Heymann EP and Goldsmith DJA
Clinical Reviews in Bone and Mineral Metabolism
Medical and Surgical Management (Including Diet)

DOI: 10.1007/s12018-011-9116-4

Heymann EP, Jenkins M and Goldsmith DJA
Clinical Reviews in Bone and Mineral Metabolism
Clinical Features and Manifestations of CKD-MBD

DOI: 10.1007/s12018-011-9115-5

Park H, Rascati KL, Keith MS, Hodgkins P, Smyth M, Goldsmith D, Akehurst R.
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective.
Value Health. 2011 Dec;14(8):1002-9.

Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Goldsmith D, Hampson G.
Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).
Bone. 2011 May 1;48(5):1127-32. Epub 2011 Jan 31. Erratum in: Bone. 2011 Sep;49(3):588.

Zoccali C, Goldsmith D, Agarwal R, Blankestijn P, Fliser D, Wiecek A, Suleymenlar G, Ortiz A, Massy Z, Covic A, Martinez-Castelao A, Jager K, Dekker F, Lindholm B, London G.
The complexity of the cardio-renal link: taxonomy, syndromes, diseases.
Kidney International Suppl 1: 2-5, 2011

Fliser D, Wiecek A, Suleymenlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Agarwal R, Jager K, Dekker F, Blankestijn P, Zoccali C, Goldsmith D, Covic A, London G, Zoccali C.
The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and kidney disease in cardiovascular disease – conditions for a research agenda.
Kidney International Suppl 1: 6-9, 2011

London G, Covic A, Goldsmith D, Wiecek A, Suleymenlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Fliser D, Agarwal R, Jager K, Dekker F, Blankestijn P, Zoccali C.
Arterial aging and arterial disease: interplay between central haemodynamics, cardiac work and organ flow- implications for CKD and cardiovascular disease.
Kidney International Suppl 1: 10-12, 2011

Blankestijn P, London G, Fliser D, Covic A, Jager K, Lindholm B, Goldsmith D, Wiecek A, Suleymenlar G, Ortiz A, Massy Z, Martinez-Castelao A, Covic A, Dekker F, Zoccali C.
Major pathways of reno-cardiovascular link: the sympathetic and renin-angiotensin systems.
Kidney International Suppl 1: 13-16, 2011.

Agarwal R, Martinez-Castelao A, Wiecek A, Massy Z, Suleymenlar G, Ortiz A, Blankestijn P, Covic A, Dekker F, Jager K, Lindholm B, Goldsmith D, Fliser D, London G, Zoccali C.
The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?
Kidney International Suppl 1: 17-20, 2011.

Jager K, Lindholm B, Goldsmith D, Fliser D, Wiecek A, Suleymenlar G, Ortiz A, Massy Z, Martinez-Castelao A, Agarwal R, Blankestijn P, Covic A, London G, Zoccali C, Dekker F.
Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link ?
Kidney International Suppl 1: 21-23, 2011.

Park H, Rascati KL, Keith MS, Hodgkins P, Smyth M, Goldsmith D, Akehurst R.
Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective.
Value Health. 2011 Dec;14(8):1002-9.

Kanbay M, Wolf M, Selcoki Y, Solak Y, Ikizek M, Uysal S, Segall L, Armutcu F, Eryonucu B, Duranay M, Goldsmith D, Covic A.
Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.
Int Urol Nephrol. 2011 Dec 1.

Sofroniadou S, Kassimatis T, Srirajaskanthan R, Reidy J, Goldsmith D.
Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.
Int Urol Nephrol. 2011 Nov 30.

Ortiz A, Massy ZA, Fliser D, Lindholm B, Wiecek A, Martínez-Castelao A, Covic A, Goldsmith D, Süleymanlar G, London GM, Zoccali C.
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.
Nat Rev Nephrol. 2011 Nov 1. doi: 10.1038/nrneph.2011.170.

Sadideen HM, Taylor JD, Goldsmith DJ.
Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism : long-term follow-up.
Int Urol Nephrol. 2011 Oct 14.

Ketteler M, Martin KJ, Cozzolino M, Goldsmith D, Sharma A, Khan S, Dumas E, Amdahl M, Marx S, Audhya P.
Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study.
Nephrol Dial Transplant. 2011 Sep 19.

Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M.
Renal anemia of inflammation: the name is self-explanatory.
Blood Purif. 2011;32(3):220-5. Epub 2011 Aug 9.

Goldsmith DJ, Covic AC.
Significant further evidence to bolster the link between epoetin and strokes in chronic kidney disease and cancer.
Kidney Int. 2011 Aug;80(3):237-9.

Goldsmith D, Covic A.
Ambulatory blood pressure measurements in chronic kidney disease: ready to (rock and) roll?
Arch Intern Med. 2011 Jun 27;171(12):1098-9.

Kanbay M, Solak Y, Covic A, Goldsmith D.
Sudden cardiac death in patients with chronic kidney disease: prevention is the sine qua non.
Kidney Blood Press Res. 2011;34(4):269-76.

Gesualdo L, London G, Turner M, Lee C, Macdonald K, Goldsmith D, Covic A, Zaoui P, Combe C, Mann J, Dellanna F, Muenzberg M, Abraham I.
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.
Intern Emerg Med. 2011 May 18.

Goldsmith DJ, Cunningham J.
Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.
Nat Rev Nephrol. 2011 Jun;7(6):341-6.

Riegersperger M, Covic A, Goldsmith D.
Allopurinol, uric acid, and oxidative stress in cardiorenal disease.
Int Urol Nephrol. 2011 Jun;43(2):441-9.

Holt S, Goldsmith D.
Renal Association Clinical Practice Guideline on cardiovascular disease in CKD.
Nephron Clin Pract. 2011;118 Suppl 1:c125-44.

Mactier R, Davies S, Dudley C, Harden P, Jones C, Kanagasundaram S, Lewington A, Richardson D, Taal M, Andrews P, Baker R, Breen C, Duncan N, Farrington K, Fluck R, Geddes C, Goldsmith D, Hoenich N, Holt S, Jardine A, Jenkins S, Kumwenda M, Lindley E, Macgregor M, Mikhail A, Sharples E, Shrestha B, Shrivastava R, Steddon S, Warwick G, Wilkie M, Woodrow G, Wright M.
Summary of the 5th edition of the Renal Association Clinical Practice Guidelines (2009-2012).
Nephron Clin Pract. 2011;118 Suppl 1:c27-70.

Kumar A, Hubbard J, Moonim M, Steddon S, Goldsmith D.
Case report: making the CONN-ection: two cases of persistent hypertension and hypokalaemia following renal transplantation.
Int Urol Nephrol. 2011 Mar 4.

Sofroniadou S, Goldsmith D.
Mammalian target of rapamycin (mTOR) inhibitors : potential uses and a review of haematological adverse effects.
Drug Saf. 2011 Feb 1;34(2):97-115.

Publications and Presentations 2010

Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Haromszeki B, Kosa JP, Lakatos P, Beko G, Sarvary E, Varga M, Fornadi K, Novak M, Rosivall L, Kiss I, Remport A, Goldsmith DJ, Kovesdy CP, Mucsi I.
Association between the malnutrition-inflammation score and post-transplant anaemia.
Nephrol Dial Transplant. 2010 Nov 29.

Gnudi L, Goldsmith D.
Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes.
F1000 Med Rep. 2010 Mar 15;2. pii: 18.

Goldsmith D.
Extraordinary popular delusions and the madness of crowds: puncturing the epoetin bubble--lessons for the future.
Nephrol Dial Transplant. 2011 Jan;26(1):24-8.

Goldsmith DJ, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R.
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.
Nephrol Dial Transplant. 2010 Dec;25(12):3823-31.

Kanbay M, Afsar B, Goldsmith D, Covic A.
Sudden death in hemodialysis: an update.
Blood Purif. 2010;30(2):135-45.

Goldsmith D, Pietrangeli CE.
The metabolic syndrome following kidney transplantation.
Kidney Int. 2010 Sep;78 Suppl 118:S8-14.

Davies JB, Crook MA, Wierzbicki AS, Goldsmith DJ.
The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic.
Int Urol Nephrol. 2010 Aug 13.

Molnar MZ, Mucsi I, Macdougall IC, Marsh JE, Yaqoob M, Main J, Courtney AE, Fogarty D, Mikhail A, Choukroun G, Short CD, Covic A, Goldsmith DJ.
Prevalence and Management of Anaemia in Renal Transplant Recipients: Data from Ten European Centres.
Nephron Clin Pract. 2010 Aug 6;117(2):c127-c134.

Kassimatis TI, Goldsmith DJ.
New hope for chronic kidney disease patients after the JUPITER trial: myth or reality?
J Am Coll Cardiol. 2010 Aug 3;56(6):529.

Goldsmith D.
The case against routine screening for vascular calcification in chronic kidney disease. Semin Dial.
2010 May-Jun;23(3):280-2.

Hayden MR, Goldsmith DJ.
Sodium thiosulfate: new hope for the treatment of calciphylaxis.
Semin Dial. 2010 May-Jun;23(3):258-62.

Covic A, Voroneanu L, Goldsmith D.
The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
Nephron Clin Pract. 2010;116(3):c187-95.

Voroneanu L, Cusai C, Hogas S, Ardeleanu S, Onofriescu M, Nistor I, Prisada O, Sascau R, Goldsmith D, Covic A.
The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.
Int Urol Nephrol. 2010 Sep;42(3):789-97.

Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ.
Vascular calcification in chronic kidney disease.
Clin Sci (Lond). 2010 Apr 28;119(3):111-21.

Goldsmith D.
2009: a requiem for rHuEPOs--but should we nail down the coffin in 2010?
Clin J Am Soc Nephrol. 2010 May;5(5):929-35.

Goldsmith D, Covic A.
Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).
Nephrol Dial Transplant. 2010 Jun;25(6):1734-7.

Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A.
Magnesium in chronic kidney disease: challenges and opportunities.
Blood Purif. 2010;29(3):280-92.

Sofroniadou S, Kassimatis T, Goldsmith D.
Anaemia, microcytosis and sirolimus--is iron the missing link?
Nephrol Dial Transplant. 2010 May;25(5):1667-75.

Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G.
Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
Osteoporos Int. 2010 Nov;21(11):1853-61.

Publications and Presentations 2009

Goldsmith D, Covic A.
Blood pressure control in CKD stage 5D patients--are we more or less certain what to do in 2009?
Nephrol Dial Transplant. 2009 Dec;24(12):3597-601.

ASTRAL Investigators, Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J.
Revascularization versus medical therapy for renal-artery stenosis.
N Engl J Med. 2009 Nov 12;361(20):1953-62.

Goldsmith D, Covic AC.
Jupiter or Aurora? Micro-inflammation and dyslipidaemia: twin targets for statin therapy in CKD.
Int Urol Nephrol. 2009 Oct 14.

Kanbay M, Turgut F, Covic A, Goldsmith D.
Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
J Nephrol. 2009 Sep-Oct;22(5):598-609.

Bramham K, Hunt BJ, Goldsmith D.
Thrombophilia of nephrotic syndrome in adults.
Clin Adv Hematol Oncol. 2009 Jun;7(6):368-72.

Sangala N, Lee RW, Horsfield C, Goldsmith DJ.
Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe.
Int Urol Nephrol. 2009 Aug 15.

Goldsmith DJ, Covic AC.
Meta-analysis of the effects of treating blood pressure on cardiovascular outcomes of dialysis patients.
Hypertension. 2009 Jul;54(1):e6; author reply e7.

Goldsmith DJ, Covic A.
Blood pressure in dialysis patients-look before we leap.
Lancet. 2009 Jun 6;373(9679):1945; author reply 1945-6.

Goldsmith D, Kothawala P, Chalian A, Bernal M, Robbins S, Covic A.
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD.
Am J Kidney Dis. 2009 Jun;53(6):1002-13. Review.

Sangala N, Goldsmith D.
Early detection of CKD will reduce heart disease risk.
Practitioner. 2009 Apr;253(1717):24-7.

Goldsmith D.
[Treating dyslipaemia in renal patients: evidences and implications].
Med Clin (Barc). 2009 May;132 Suppl 1:27-32. Spanish.

Pasha Y, Gusbeth-Tatomir P, Covic A, Goldsmith D.
Direct renin inhibitors: ONTARGET for success?
Int Urol Nephrol. 2009;41(2):341-55. Review.

Kanbay M, Goldsmith D, Akcay A, Covic A.
Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review.
Blood Purif. 2009;27(2):220-30.

Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D.
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease.
Nephrol Dial Transplant. 2009 May;24(5):1506-23

Publications and Presentations 2008

Roger SD, Goldsmith D.
Biosimilars: it's not as simple as cost alone.
J Clin Pharm Ther. 2008 Oct;33(5):459-64.

Covic A, Cannata-Andia J, Cancarini G, Coppo R, Frazão JM, Goldsmith D, Ronco P, Spasovski GB, Stenvinkel P, Utas C, Wiecek A, Zoccali C, London G.
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council.
Nephrol Dial Transplant. 2008 Dec;23(12):3731-7.

Covic A, Seica A, Gusbeth-Tatomir P, Goldsmith D.
Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
J Nephrol. 2008 Jul-Aug;21(4):478-84. Review.

Sadideen HM, Blaker P, O'Donnell P, Taylor J, Goldsmith DJ.
Tuberculosis complicating tertiary hyperparathyroidism in a patient with end-stage renal disease: a case report.
J Nephrol. 2008 May-Jun;21(3):438-41.

Cannata-Andía JB, Fernández-Martín JL, Zoccali C, London GM, Locatelli F, Ketteler M, Ferreira A, Covic A, Floege J, Górriz JL, Rutkowski B, Memmos DE, Verbeelen D, Tielemans C, Teplan V, Bos WJ, Nagy J, Kramar R, Goldsmith DJ, Martin PY, Wüthrich RP, Pavlovic D, Benedik M.
Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS).
J Nephrol. 2008 May-Jun;21(3):290-8.

Mikhail A, Covic A, Goldsmith D.
Stimulating erythropoiesis: future perspectives.
Kidney Blood Press Res. 2008;31(4):234-46. Epub 2008 Jun 28. Review.

Hutchison AJ, Laville M;
SPD405-313 Lanthanum Study Group. Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden.
Nephrol Dial Transplant. 2008 Nov;23(11):3677-84. Epub 2008 Jun 24. PubMed PMID: 18577536; PubMed Central PMCID: PMC2568007.

Hull RP, Goldsmith DJ.
Nephrotic syndrome in adults.
BMJ. 2008 May 24;336(7654):1185-9. Review.

Hull R, Goldsmith D.
Identifying and managing nephrotic syndrome in adults.
Practitioner. 2008 Feb;252(1703):30, 32-4, 37. Review.

Khan MS, Ahmed S, Challacombe B, Goldsmith D, Steward M.
Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplant.
Int Urol Nephrol. 2008;40(2):547-50.

Hayden MR, Goldsmith D, Sowers JR, Khanna R.
Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.
Int Urol Nephrol. 2008;40(2):443-51. Review.

Taylor MJ, Elgazzar HA, Chaplin S, Goldsmith D, Molony DA.
An economic evaluation of sevelamer in patients new to dialysis.
Curr Med Res Opin. 2008 Feb;24(2):601-8.

Publications and Presentations 2007

Francesco Locatelli, David Goldsmith (2007)
Biosimilars: uncharted territory.
J Nephrol 20: 3. 265-267 May/Jun

Behdad Afzali, David J A Goldsmith (2007)
Long-term risks of increased use of intravenous iron.
Lancet 370: 9586. 482; author reply 482-482; author reply 483 Aug

Adrian Covic, David J A Goldsmith (2007)
Final Word: The binders wars 2007-2017: "The truth is out there somewhere...".
Semin Dial 20: 2. 170-171 Mar/Apr

Kerem Atalar, Behdad Afzali, Boris Lams, M Fahim Tungekar, David J A Goldsmith (2007)
Falls, hypokalaemia, and a dry mouth.
Lancet 370: 9582. Jul

A Laurence, S M Edbury, A M Marinaki, R T Smolenski, D J A Goldsmith, H A Simmonds, E A Carrey (2007)
4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism.
Clin Exp Med 7: 4. 135-141 Dec

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith (2007)
Vascular calcification--a new window on the cardiovascular system: role of agents used to manipulate skeletal integrity.
Semin Dial 20: 2. 158-169 Mar/Apr

Liviu Segall, Adrian Covic, David J A Goldsmith (2007)
Direct renin inhibitors: the dawn of a new era, or just a variation on a theme?
Nephrol Dial Transplant 22: 9. 2435-2439 Sep

Nigel Kendall, David Goldsmith (2007)
Tackling the QOF2 indicators for CKD.
Practitioner 251: 1691. Feb

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith (2007)
Current dilemmas in inhibiting the renin-angiotensin system: do not forget real life.
Int Urol Nephrol 39: 2. 571-576 05

David Goldsmith (2007)
Early recognition the key to CKD.
Practitioner 251: 1691. 35-6, 38, 41-2 Feb

S Al-Khoury, B Afzali, N Shah, S Thomas, P Gusbeth-Tatomir, D Goldsmith, A Covic (2007)
iabetes, kidney disease and anaemia: time to tackle a troublesome triad?
Int J Clin Pract 61: 2. 281-289 Feb

David Goldsmith, Martin Kuhlmann, Adrian Covic (2007)
Through the looking glass: the protein science of biosimilars.
Clin Exp Nephrol 11: 3. 191-195 Sep

Anil V Kamat, David Goldsmith, Patrick O'Donnell, Jon van der Walt, Robert Carr (2007)
Renal failure with granulomatous interstitial nephritis and diffuse leukemic renal infiltration in chronic lymphocytic leukemia.
Ren Fail 29: 6. 763-765

Silke Schelenz, Kate Bramham, David Goldsmith (2007)
Septic arthritis due to extended spectrum beta lactamase producing Klebsiella pneumoniae.
Joint Bone Spine 74: 3. 275-278 May

Ashraf Mikhail, David Goldsmith (2007)
Chronic kidney disease, anemia, and epoetin.
N Engl J Med 356: 9. 956-7; author reply 958-9 Mar

Publications and Presentations 2006

H A Simmonds, J S Cameron, D J Goldsmith, L D Fairbanks, G Venkat Raman (2006)
Familial juvenile hyperuricaemic nephropathy is not such a rare genetic metabolic purine disease in Britain. Nucleosides Nucleotides
Nucleic Acids 25: 9-11. 1071-1075

Michele Kessler, David Goldsmith, Huub Schellekens (2006)
Immunogenicity of biopharmaceuticals.
Nephrol Dial Transplant 21 Suppl 5: v9-12 Oct

Behdad Afzali, Salam Al-Khoury, Nilesh Shah, Ashraf Mikhail, Adrian Covic, David Goldsmith (2006)
Anemia after renal transplantation.
Am J Kidney Dis 48: 4. 519-536 Oct

Adrian Covic, Nicoleta Mardare, Paul Gusbeth-Tatomir, Ovidiu Brumaru, Cristina Gavrilovici, Mihaela Munteanu, Octavian Prisada, David J A Goldsmith (2006)
Increased arterial stiffness in children on haemodialysis.
Nephrol Dial Transplant 21: 3. 729-735 Mar

Adrian Covic, Nicoleta G I Mardare, Serban Ardeleanu, Octavian Prisada, Paul Gusbeth-Tatomir, David J A Goldsmith (2006)
Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation.
J Nephrol 19: 6. 783-793 Nov/Dec

David Goldsmith (2006)
Uptake of biosimilar therapies--opportunities and obstacles. Commentary.
Nephrol Dial Transplant 21 Suppl 5: v1-v3 Oct

R W C Kingston, D J A Goldsmith (2006)
Chronic renal allograft dysfunction: the evidence for a change in immunosuppression.
Minerva Urol Nefrol 58: 1. 23-28 Mar

N J Cortes, B Afzali, D MacLean, D J A Goldsmith, H O'Sullivan, J Bingham, D A Lewis, E MacMahon, C Y W Tong, G Koffman (2006)
Transmission of syphilis by solid organ transplantation.
Am J Transplant 6: 10. 2497-2499 Oct

David Goldsmith, Salam Al-Khoury, Nilesh Shah, Adrian Covic (2006)
Anaemia after renal transplantation--role of immunosuppressive drugs and a pathophysiological appraisal.
Nephron Clin Pract 104: 2. c69-c74 06

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith (2006)
Is it time for spironolactone therapy in dialysis patients?
Nephrol Dial Transplant 21: 4. 854-858 Apr

S Al-Khoury, B Afzali, N Shah, A Covic, S Thomas, D J Goldsmith (2006)
Anaemia in diabetic patients with chronic kidney disease--prevalence and predictors.
Diabetologia 49: 6. 1183-1189 Jun

Ali A Haydar, Antoine B Abchee, Ihab I El-Hajj, Nabil M A Hujairi, Amer S Tfaili, Tarek Hatoum, Ayman Quateen, Rashed Bakri, Behdad Afzali, David J A Goldsmith (2006)
Bleeding post coronary artery bypass surgery. Clopidogrel--cure or culprit?
J Med Liban 54: 1. 11-16 Jan/Mar

Adrian Covic, Nicoleta Mardare, Paul Gusbeth-Tatomir, Octavian Prisada, Radu Sascau, David J A Goldsmith (2006)
Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised?
Nephrol Dial Transplant 21: 10. 2859-2866 Oct

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith (2006)
The epidemics of cardiovascular disease in elderly patients with chronic kidney disease--two facets of the same problem.
Int Urol Nephrol 38: 2. 371-379

Salam Al-Khoury, Nilesh Shah, Behdad Afzali, Adrian Covic, Judy Taylor, David Goldsmith (2006)
Post-transplantation anaemia in adult and paediatric renal allograft recipients-Guy's Hospital experience.
Nephrol Dial Transplant 21: 7. 1974-1980 Jul

Publications and Presentations 2005

Adrian Covic, Paul Gusbeth-Tatomir, Nicoleta Mardare, Irina Buhaescu, David J A Goldsmith (2005)
Dynamics of the circadian blood pressure profiles after renal transplantation.
Transplantation 80: 9. 1168-1173 Nov

Adrian Covic, Nicoleta Mardare, Paul Gusbeth-Tatomir, Irina Buhaescu, David J A Goldsmith (2005)
Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients.
Kidney Int 67: 2. 732-737 Feb

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith (2005)
Arterial stiffness in renal patients: an update.
Am J Kidney Dis 45: 6. 965-977 Jun

Nicoleta-Genoveva Mardare, David J A Goldsmith, Paul Gusbeth-Tatomir, Adrian Covic (2005)
Intradialytic changes in reflective properties of the arterial system during a single hemodialysis session.
Hemodial Int 9: 4. 376-382 Oct

Ben Challacombe, Prokar Dasgupta, Richard Tiptaft, Jonathan Glass, Geoff Koffman, David Goldsmith, Mohammed S Khan (2005)
Multimodal management of urolithiasis in renal transplantation.
BJU Int 96: 3. 385-389 Aug

Andrew Smith, Janaka Karalliedde, Lorenita De Angelis, David Goldsmith, Giancarlo Viberti (2005)
Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes.
J Am Soc Nephrol 16: 4. 1069-1075 Apr

A Covic, A A Haydar, P Bhamra-Ariza, P Gusbeth-Tatomir, D J Goldsmith (2005)
Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients.
J Nephrol 18: 4. 388-396 Jul/Aug

Emanuela Orlandi, Asif Butt, David Goldsmith, R Swaminathan (2005)
Factors affecting circulating mRNA for nephrin.
Clin Chem 51: 10. 1982-1983 Oct

Behdad Afzali, Anna L Taylor, David J A Goldsmith (2005)
What we CAN do about chronic allograft nephropathy: role of immunosuppressive modulations.
Kidney Int 68: 6. 2429-2443 Dec

Behdad Afzali, Sapna Shah, Paramit Chowdhury, Helen O'sullivan, John Taylor, David Goldsmith (2005)
Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy.
Transplantation 79: 3. 304-309 Feb

Publications and Presentations 2004

Behdad Afzali, Ali A Haydar, Katie Vinen, David J A Goldsmith (2004)
From Finland to fatland: beneficial effects of statins for patients with chronic kidney disease.
J Am Soc Nephrol 15: 8. 2161-2168 Aug

Adrian Covic, David J A Goldsmith, Laura Florea, Paul Gusbeth-Tatomir, Maria Covic (2004)
The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function.
Perit Dial Int 24: 4. 365-372 Jul/Aug

David Goldsmith, Eberhard Ritz, Adrian Covic (2004)
Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease?
Kidney Int 66: 4. 1315-1333 Oct

A M Elsharkawy, F Perrin, C K T Farmer, I C Abbs, P Muir, L J Brown, E M E MacMahon, D J A Goldsmith (2004)
Symptomatic cytomegalovirus infection complicating treatment of acute systemic vasculitis.
Clin Nephrol 62: 4. 319-326 Oct

E A Carrey, R T Smolenski, S M Edbury, A Laurence, A M Marinaki, J A Duley, L M Zhu, D J A Goldsmith, H A Simmonds (2004)
An unusual pyridine nucleotide accumulating in erythrocytes: its identity and positive correlation with degree of renal failure.
Nucleosides Nucleotides Nucleic Acids 23: 8-9. 1135-1139 Oct

Behdad Afzali, David J A Goldsmith (2004)
Intravenous iron therapy in renal failure: friend and foe?
J Nephrol 17: 4. 487-495 Jul/Aug

D J A Goldsmith, E A Carrey, S M Edbury, A M Marinaki, H A Simmonds (2004)
GTP concentrations are elevated in erythrocytes of renal transplant recipients when conventional immunosuppression is replaced by the inosine monophosphate dehydrogenase inhibitor mycophenolic acid mofetil (MMF).
Nucleosides Nucleotides Nucleic Acids 23: 8-9. 1407-1409 Oct

Ali A Haydar, Nabil M Hujairi, Aiman Quateen, Tarek Hatoum, David J A Goldsmith (2004)
Massive bilateral perirenal hematoma following urinary catheterization for urinary obstruction.
Int J Urol 11: 8. 663-665 Aug

A A Haydar, A Li, R Hilton, B Lams, R Hangartner, M Weber, D J A Goldsmith (2004)
Eosinophilia and symptomatic pulmonary amyloidosis.
Postgrad Med J 80: 950. 738-739 Dec

Ihab I Elhajj, Ali A Haydar, Nabil M Hujairi, David J Goldsmith (2004)
The role of inflammation in acute coronary syndromes: review of the literature.
J Med Liban 52: 2. 96-102 Apr/Jun

Ali A Haydar, Mark Denton, Alex West, John Rees, David J A Goldsmith (2004)
Sirolimus-induced pneumonitis: three cases and a review of the literature.
Am J Transplant 4: 1. 137-139 Jan

B Afzali, D J A Goldsmith (2004)
Beneficial effects of statins on the kidney.
J Clin Pathol 57: 7. 673-674 Jul

Ali A Haydar, David J A Goldsmith (2004)
Pulmonary embolism--or vasculitis?
J R Soc Med 97: 1. 27-28 Jan

Piotr Jagodzinski, Slawomir Lizakowski, Ryszard T Smolenski, Ewa M Slominska, David Goldsmith, H Anne Simmonds, Boleslaw Rutkowski (2004)
Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes.
Clin Sci (Lond) 107: 1. 69-74 Jul

David Goldsmith, Elizabeth A Carrey, Stephen Edbury, Ryszard T Smolenski, Piotr Jagodzinski, H Anne Simmonds (2004)
Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
Clin Sci (Lond) 107: 1. 63-68 Jul

Cristina Gavrilovici, David J A Goldsmith, Chris Reid, Paul Gubeth-Tatomir, Adrian Covic (2004)
What is the role of ambulatory BP monitoring in pediatric nephrology?
J Nephrol 17: 5. 642-652 Sep/Oct

Edward J Sharples, Divaka Pereira, Shaun Summers, John Cunningham, Michael Rubens, David Goldsmith, Muhammad M Yaqoob (2004)
Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients.
Am J Kidney Dis 43: 2. 313-319 Feb

Ali A Haydar, David J A Goldsmith (2004)
Dyslipidemia and the risk of end stage renal disease.
J Med Liban 52: 3. 156-159 Jul/Sep

Adrian Covic, David J A Goldsmith, Paul Gusbeth-Tatomir, Maria Covic (2004)
Haemodialysis acutely improves endothelium-independent vasomotor function without significantly influencing the endothelium-mediated abnormal response to a beta 2-agonist.
Nephrol Dial Transplant 19: 3. 637-643 Mar

Behdad Afzali, Ali A Haydar, Katie Vinen, David J A Goldsmith (2004)
Beneficial effects of statins on the kidney: the evidence moves from mouse to man.
Nephrol Dial Transplant 19: 5. 1032-1036 May

Karim Bakri, Ali A Haydar, Jeremy Davis, Jon Wan Der Walt, Majid Kazmi, David J A Goldsmith (2004)
Waldenström's macroglobulinaemia presenting as isolated epistaxis: a common complaint but a rare cause.
Int J Clin Pract 58: 1. 81-82 Jan

Ali A Haydar, Adrian Covic, Satish Jayawardene, Mohsen Agharazii, Eilish Smith, Isabel Gordon, Helen O'Sullivan, David J A Goldsmith (2004)
Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients.
Transplantation 77: 6. 849-853 Mar

Rashed S Bakri, Behdad Afzali, Adrian Covic, Rajaventhan Sriskantharan, Paul Bharma-Ariza, Won-Ho Park, Mohanaluxmi Sriharan, Neil Dalton, Anthony S Wierzbicki, Martin A Crook, David J A Goldsmith (2004)
Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation.
Clin Transplant 18: 2. 201-204 Apr

Ali A Haydar, Adrian Covic, Mohsen Agharazii, Satish Jayawardene, John Taylor, David J A Goldsmith (2004)
Systolic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients.
Am J Transplant 4: 2. 244-247 Feb

Ali A Haydar, Adrian Covic, Helen Colhoun, Michael Rubens, David J A Goldsmith (2004)
Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients.
Kidney Int 65: 5. 1790-1794 May

Ali A Haydar, Nabil Hujairi, Paramit Chowdhury, James Pattison, Allan Deacon, Robert Sarkany, David J A Goldsmith (2004)
What's in a blister? A diagnostic twister.
Nephrol Dial Transplant 19: 5. 1321-1322 May

Ali A Haydar, Nabil Hujairi, Bruce Kirkham, Robert Hangartner, David J A Goldsmith (2004)
hronic overdose of leflunomide inducing interstitial nephritis.
Nephrol Dial Transplant 19: 5. 1334-1335 May

Ophelia Dadzie, Nabil Ma Hujairi, Cliff Bucknall, Simon Redwood, Michael Rubens, David Goldsmith (2004)
Inflammation and coronary calcification in renal patients--factors that may explain increased cardiovascular risk, and poorer results of coronary interventions?
J Nephrol 17: 1. 118-124 Jan/Feb

A Covic, O Golea, L Segall, Srinath Meadipudi, Liliana Munteanu, M Nicolicioiu, V Tudorache, Maria Covic, D J A Goldsmith (2004)
A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases.
J Indian Med Assoc 102: 1. 20, 22-20, 25 Jan

Ali A Haydar, Nabil M A Hujairi, Adrian A Covic, Divaka Pereira, Michael Rubens, David J A Goldsmith (2004)
Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography.
Nephrol Dial Transplant 19: 9. 2307-2312 Sep

Adrian Covic, Ali A Haydar, David Goldsmith (2004)
Ambulatory blood pressure monitoring in hemodialysis patients: a critique and literature review.
Semin Dial 17: 4. 255-259 Jul/Aug

Publications and Presentations 2003

Sally Evans, Robson Michael, Hayley Wells, Douglas Maclean, Isabel Gordon, John Taylor, David Goldsmith (2003)
Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat.
Am J Kidney Dis 41: 2. 493-496 Feb

Michael Robson, Isabelle Côte, Ian Abbs, Geoffrey Koffman, David Goldsmith (2003)
Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?
Am J Transplant 3: 3. 324-327 Mar

S A Jayawardene, D J A Goldsmith (2003)
Staghorn calculi complicating renal transplantation in patients with persistent post-transplantation hyperparathyroidism.
Clin Nephrol 59: 3. 222-224 Mar

B Afzali, D J A Goldsmith (2003)
Successful retransplantation using rapamycin in a patient with previous calcineurin inhibitor-induced posterior leukoencephalopathy syndrome.
Clin Nephrol 59: 3. 225-228 Mar

Adrian Covic, David J A Goldsmith, Paul Gusbeth-Tatomir, Anca Seica, Maria Covic (2003)
A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature.
Nephrol Dial Transplant 18: 6. 1128-1134 Jun

Narbeh Melikian, John Bingham, David J A Goldsmith (2003)
Diabetic muscle infarction: an unusual cause of acute limb swelling in patients on hemodialysis.
Am J Kidney Dis 41: 6. 1322-1326 Jun

Rashed Bakri, Cormac Breen, Douglas Maclean, John Taylor, David Goldsmith (2003)
Serious interaction between tacrolimus FK506 and chloramphenicol in a kidney-pancreas transplant recipient.
Transpl Int 16: 6. 441-443 Jun

Ali Haydar, Rashed S Bakri, Matthew Prime, David J A Goldsmith (2003)
Page kidney--a review of the literature.
J Nephrol 16: 3. 329-333 May/Jun

Karim Bakri, David J A Goldsmith (2003)
Accelerated progression of calcific aortic stenosis in dialysis patients: what we still need to learn.
Nephron Clin Pract 94: 2. c27-c28

Timothy Doulton, Nikhant Sabharwal, Hugh S Cairns, Silke Schelenz, Susannah Eykyn, Patrick O'Donnell, John Chambers, Conell Austen, David J A Goldsmith (2003)
Infective endocarditis in dialysis patients: new challenges and old.
Kidney Int 64: 2. 720-727 Aug

Jens Rocktaeschel, Hiroshi Morimatsu, Shigehiko Uchino, Donna Goldsmith, Stephanie Poustie, David Story, Geoffrey Gutteridge, Rinaldo Bellomo (2003)
Acid-base status of critically ill patients with acute renal failure: analysis based on Stewart-Figge methodology.
Crit Care 7: 4. Aug

Rashed S Bakri, Matthew Prime, Ali Haydar, Jonathan Glass, David J A Goldsmith (2003)
Three 'Pages' in a chapter of accidents.
Nephrol Dial Transplant 18: 9. 1917-1919 Sep

Rachel Jones, Sapna Shah, Eithne E M MacMahon, David J A Goldsmith (2003)
Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.
Nephrol Dial Transplant 18: 9. 1920-1922 Sep

W Al-Hakim, D J A Goldsmith (2003)
Bilateral popliteal aneurysms complicating adult polycystic kidney disease in a patient with a marfanoid habitus.
Postgrad Med J 79: 934. 474-475 Aug

A Slack, D J A Goldsmith (2003)
An unusual cause of peripheral neuropathy in a diabetic patient on dialysis: "a sural surprise".
Postgrad Med J 79: 934. 477, 480-477, 481 Aug

Rashed Bakri, Joe Wang, Anthony S Wierzbicki, David Goldsmith (2003)
Cerivastatin monotherapy-induced muscle weakness, rhabdomyolysis and acute renal failure.
Int J Cardiol 91: 1. 107-109 Sep

S Schelenz, D J A Goldsmith (2003)
Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients.
J Infect 47: 4. 336-343 Nov

Adrian Covic, Ali A Haydar, David J A Goldsmith (2003)
Recent insights from studies using ambulatory blood pressure monitoring in patients with renal disease.
Curr Opin Nephrol Hypertens 12: 6. 645-648 Nov

Adrian Covic, Paul Gusbeth-Tatomir, David J A Goldsmith (2003)
The challenge of cardiovascular risk factors in end-stage renal disease.
J Nephrol 16: 4. 476-486 Jul/Aug

Adrian Covic, David J A Goldsmith, Paul Gusbeth-Tatomir, Carmen Volovat, Alexandru G Dimitriu, Florin Cristogel, Aurel Bizo (2003)
Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion.
Liver Int 23 Suppl 3: 21-27.

S Holiday, D J A Goldsmith (2003)
Sarcoidosis emerging after adrenalectomy for Cushing's syndrome.
Int J Clin Pract 57: 3. 241-242 Apr

A Covic, D J A Goldsmith, P Gusbeth-Tatomir, I Buhaescu, M Covic (2003)
Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients.
Transplantation 76: 11. 1573-1577 Dec

Adrian Covic, Liviu Segall, David J A Goldsmith (2003)
Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients?
Transplantation 76: 11. 1640-1642 Dec

Behdad Afzali, Rached S Bakri, Paul Bharma-Ariza, Peter J Lumb, Neil Dalton, Neil C Turner, Anthony S Wierzbicki, Martin A Crook, David J Goldsmith (2003)
Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
J Nephrol 16: 4. 540-545 Jul/Aug

Adeel Ansari, Stephen Thomas, David Goldsmith (2003)
Assessing glycemic control in patients with diabetes and end-stage renal failure.
Am J Kidney Dis 41: 3. 523-531 Mar

A Covic, D J Goldsmith, P Gusbeth-Tatomir, Anca Seica, S Jayawardene, M Agharazii, B Afzali (2003)
What added value does ambulatory blood pressure monitoring brings to the management of post renal transplantation hypertension?
Rev Med Chir Soc Med Nat Iasi 107: 1. 89-97 Jan/Mar

S A Jayawardene, A Covic, N Malikian, W J Owen, P O'Donnell, J Taylor, G C Koffman, D J Goldsmith (2003)
Atypical post-renal transplantation hyperparathyroidism--further support for "removing all enlarged glands".
Rev Med Chir Soc Med Nat Iasi 107: 3. 636-640 Jul/Sep

Publications and Presentations 2002

S A Jayawardene, J E Scoble, D J A Goldsmith (2002)
Nephrotic syndrome: more than just oedema.
Int J Clin Pract 56: 2. 129-131 Mar

Martin Plaisance, David J A Goldsmith (2002)
Spontaneous and protracted partial remission of microscopic polyangiitis.
Am J Kidney Dis 39: 5. 1113-1117 May

David Goldsmith, Robert MacGinley, Andrew Smith, Adrian Covic (2002)
How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure?
Nephrol Dial Transplant 17: 6. 965-969 Jun

L D Fairbanks, J S Cameron, G Venkat-Raman, S P A Rigden, L Rees, W Van'T Hoff, M Mansell, J Pattison, D J A Goldsmith, H A Simmonds (2002)
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.
QJM 95: 9. 597-607 Sep

Adrian Covic, David J A Goldsmith (2002)
Ambulatory blood pressure measurement in the renal patient.
Curr Hypertens Rep 4: 5. 369-376 Oct

M Chak, M R Stanford, W Poon, E M Graham, M F Tungekar, D Goldsmith (2002)
Uveitis initiating an autoimmune reaction resulting in Goodpasture's syndrome in a Chinese man.
Br J Ophthalmol 86: 10. 1188-1190 Oct

Adrian Covic, David Goldsmith (2002)
Ambulatory blood pressure monitoring: an essential tool for blood pressure assessment in uraemic patients.
Nephrol Dial Transplant 17: 10. 1737-1741 Oct

Satishkumar A Jayawardene, David J A Goldsmith (2002)
Rectus sheath haematomata in patients with renal disease.
Nephrol Dial Transplant 17: 10. 1832-1835 Oct

J Smyth, R S Bakri, A Covic, D J A Goldsmith (2002)
New markers and therapies for coronary artery disease in renal patients.
Minerva Urol Nefrol 54: 3. 157-162 Sep

H Brown, P Luce, J Dussek, J E Scoble, D J A Goldsmith (2002)
Laudable pus - lardaceous kidneys.
Am J Nephrol 22: 4. 394-396 Jul/Aug

Robert MacGinley, Katrina Cooney, Geraldine Alexander, SueMien Cohen, David J A Goldsmith (2002)
Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
Am J Kidney Dis 40: 5. 1030-1035 Nov

Adrian Covic, Mirela Diaconita, Paul Gusbeth-Tatomir, Maria Covic, Adrian Botezan, Gabriel Ungureanu, David J Goldsmith (2002)
Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease.
Nephrol Dial Transplant 17: 12. 2170-2177 Dec

Ronak Rajani, John Smyth, C Geoff Koffman, Ian Abbs, David J A Goldsmith (2002)
Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis.
Nephrol Dial Transplant 17: 12. 2278-2280 Dec

Adrian Covic, Irina Mititiuc, Paul Gusbeth-Tatomir, David J Goldsmith (2002)
The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
J Nephrol 15: 5. 497-506 Sep/Oct

Publications and Presentations 2001

D Goldsmith, W J Owen (2001)
Persistent post-transplant autonomous hyperparathyroidism despite 23 years of excellent renal allograft function.
Nephron 89: 1. 105-107 Sep

S Mehmet, G Quan, S Thomas, D Goldsmith (2001)
Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis.
Diabet Med 18: 8. 679-682 Aug

A C Covic, D J Goldsmith, L Florea, P Gusbeth, C Volovat, T Taranu, N Suditu, C Novac, M Covic (2001)
Should CAPD be the first choice for dialysis in Romania? Audit of the Iasi 'C. I. Parhon' Dialysis Center: 1995-2000.
Nephrol Dial Transplant 16: 10. 1996-2001 Oct

D J Goldsmith, A Covic (2001)
Coronary artery disease in uremia: Etiology, diagnosis, and therapy.
Kidney Int 60: 6. 2059-2078 Dec

D J Goldsmith, M M Black (2001)
Skin disorders in the setting of renal failure: invited editorial.
J Eur Acad Dermatol Venereol 15: 5. 392-398 Sep

S A Jayawardene, N Sheerin, J M Pattison, B Hartley, D J Goldsmith (2001)
Spontaneous abdominal hemorrhage with AA-amyloidosis and vasculitis in a patient with rheumatoid arthritis.
J Clin Rheumatol 7: 2. 86-90 Apr

S Uppal, N Saravanappa, J P Davis, C K Farmer, D J Goldsmith (2001)
Pulmonary Wegener's granulomatosis misdiagnosed as malignancy.
BMJ 322: 7278. 89-90 Jan

D Goldsmith (2001)
ACE inhibitors for all--'Hope' for the heart and failure for the kidneys?
J Hum Hypertens 15: 3. 147-151 Mar

C K Farmer, D J Goldsmith (2001)
Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma.
Postgrad Med J 77: 907. 333-334 May

D J Goldsmith, A Covic (2001)
Coronary artery disease in patients with renal failure.
Int J Clin Pract 55: 3. 196-210 Apr

R Masterson, N Sheerin, I Abbs, D Goldsmith (2001)
Late allograft loss due to recurrence of p-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis.
Nephrol Dial Transplant 16: 8. 1705-1707 Aug

Publications and Presentations 2000

D Goldsmith, A Cork (2000)
Blood pressure variability measurements.
Nephrol Dial Transplant 15: 1. 131-132 Jan

D J Goldsmith, A Covic (2000)
Prolonged slow dialysis and better survival.
Am J Kidney Dis 35: 2. 361-362 Feb

A Covic, D J Goldsmith, M Covic (2000)
Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients.
Am J Kidney Dis 35: 4. 617-623 Apr

A Covic, D J Goldsmith, L Panaghiu, M Covic, J Sedor (2000)
Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms.
Kidney Int 57: 6. 2634-2643 Jun

M Melzer, D Goldsmith, W Gransden (2000)
Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
Clin Infect Dis 31: 1. 208-209 Jul

D J Goldsmith, C K Farmer (2000)
Autonomic neuropathy with B-cell lymphoma.
J R Soc Med 93: 7. 377-378 Jul

D Goldsmith (2000)
High blood pressure and the kidney.
Kidney Int 58: 3. Sep

D J Goldsmith, J Reidy, J Scoble (2000)
Renal arterial intervention and angiotensin blockade in atherosclerotic nephropathy.
Am J Kidney Dis 36: 4. 837-843 Oct

S Jayawardene, W J Owen, D J Goldsmith (2000)
Parathyroid carcinoma in a dialysis patient.
Am J Kidney Dis 36: 4. Oct

M J Dayer, W Gransden, D J Goldsmith (2000)
Facet joint osteomyelitis in a patient on long-term hemodialysis.
Am J Kidney Dis 36: 5. 1041-1044 Nov

H Tahir, G Thomas, N Sheerin, H Bettington, J M Pattison, D J Goldsmith (2000)
Successful medical treatment of acute bilateral emphysematous pyelonephritis.
Am J Kidney Dis 36: 6. 1267-1270 Dec

D Goldsmith, S Jayawardene, N Sabharwal, K Cooney (2000)
Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure.
Lancet 355: 9207. Mar

Publications and Presentations 1999

D J Goldsmith, P Thomas (1999)
Images in clinical medicine. von Hippel-Lindau disease.
N Engl J Med 340: 24. Jun

P Glynne, A Deacon, D Goldsmith, C Pusey, E Clutterbuck (1999)
Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria?
Am J Kidney Dis 34: 1. 155-160 Jul

A Covic, D J Goldsmith (1999)
Ambulatory blood pressure monitoring in nephrology: focus on BP variability.
J Nephrol 12: 4. 220-229 Jul/Aug

A Covic, D J Goldsmith, M C Venning, P Ackrill (1999)
Long-hours home haemodialysis--the best renal replacement therapy method?
QJM 92: 5. 251-260 May

A Covic, D J Goldsmith, C K Farmer, J Cox, P Dallyn, P Sharpstone, J C Kingswood (1999)
How reproducible is diurnal blood pressure rhythm in patients with secondary (renal) hypertension?
Rev Med Chir Soc Med Nat Iasi 103: 1-2. 88-93 Jan/Jun

Publications and Presentations 1998

D J Goldsmith (1998)
Coronary artery calcification on computed tomography.
Lancet 351: 9100. 447; author reply 447-447; author reply 448 Feb

C K Farmer, D J Goldsmith, P Sharpstone, J C Kingswood (1998)
Maintenance of adequate dialysis in a patient with peritoneal calcification using tidal peritoneal dialysis.
Clin Nephrol 49: 1. 55-58 Jan

C K Farmer, D J Goldsmith, J D Quin, P Dallyn, J Cox, J C Kingswood, P Sharpstone (1998)
Progression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level?
Nephrol Dial Transplant 13: 3. 635-639 Mar

A Covic, D J Goldsmith, L Segall, C Stoicescu, S Lungu, C Volovat, M Covic (1998)
Rifampicin-induced acute renal failure: a series of 60 patients.
Nephrol Dial Transplant 13: 4. 924-929 Apr

F Zulian, H R Schumacher, A Calore, D P Goldsmith, B H Athreya (1998)
Juvenile arthritis in Turner's syndrome: a multicenter study.
Clin Exp Rheumatol 16: 4. 489-494 Jul/Aug

D J Goldsmith, G Hamilton (1998)
Hypertension and renal failure.
Postgrad Med J 74: 871. 263-265 May

D J Goldsmith (1998)
Relationships between volume status and blood pressure in haemodialysis patients--the long and the short of it?
Nephrol Dial Transplant 13: 8. 2164-2166 Aug

A M Wardley, G C Jayson, D J Goldsmith, M C Venning, P Ackrill, J H Scarffe (1998)
The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone.
Br J Cancer 78: 6. 774-776 Sep

A Covic, D J Goldsmith, K Hill, M C Venning, P Ackrill (1998)
Urea kinetic modelling--are any of the 'bedside' Kt/V formulae reliable enough?
Nephrol Dial Transplant 13: 12. 3138-3146 Dec

D Goldsmith (1998)
Organ calcification in renal hyperparathyroidism.
J R Soc Med 91: 11. Nov

Publications and Presentations 1997-1989

M Ostermann, D J Goldsmith, T Doyle, J C Kingswood, P Sharpstone (1997)
Reversible acute renal failure induced by losartan in a renal transplant recipient.
Postgrad Med J 73: 856. 105-107 Feb

D J Goldsmith, A C Covic, M C Venning, P Ackrill (1997)
Ambulatory blood pressure monitoring in renal dialysis and transplant patients.
Am J Kidney Dis 29: 4. 593-600 Apr

D J Goldsmith (1997)
Angiotensin receptor antagonists.
Lancet 349: 9060. Apr

D J Goldsmith (1997)
Calciphylaxis, thrombotic diathesis and defects in coagulation regulation.
Nephrol Dial Transplant 12: 5. 1082-1083 May

D J Goldsmith (1997)
Tackling ACE inhibitor cough.
Lancet 350: 9080. Sep

E C Chalom, D P Goldsmith, M A Koehler, B Bittar, C D Rose, B E Ostrov, G F Keenan (1997)
Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis.
J Rheumatol 24: 10. 2031-2034 Oct

C K Farmer, E Greenwood, D J Goldsmith, J C Kingswood, P Sharpstone (1997)
Endoluminal brushing of blocked permanent indwelling haemodialysis catheters saves money.
Nephrol Dial Transplant 12: 9. Sep

C K Farmer, D J Goldsmith, J Cox, P Dallyn, J C Kingswood, P Sharpstone (1997)
An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability.
Nephrol Dial Transplant 12: 11. 2301-2307 Nov

D J Goldsmith (1997)
Calcifying panniculitis or 'simple' inflammation? Biopsy is better than a bone scan.
Nephrol Dial Transplant 12: 11. 2463-2464 Nov

D J Goldsmith, A Covic, P A Sambrook, P Ackrill (1997)
Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis.
Nephron 77: 1. 37-43

D J Goldsmith (1997)
Left ventricular consequences of renal transplantation and calcium-channel blockers.
Nephrol Dial Transplant 12: 12. 2793-2794 Dec

D J Goldsmith, L G Forni, P J Hilton (1997)
Bicarbonate therapy and intracellular acidosis.
Clin Sci (Lond) 93: 6. 593-598 Dec

Publications and Presentations 1996

R M Higgins, D J Goldsmith, J Connolly, J E Scoble, B M Hendry, P Ackrill, M C Venning (1996)
Vasculitis and rapidly progressive glomerulonephritis in the elderly.
Postgrad Med J 72: 843. 41-44 Jan

P Donohoe, D de Takats, N Bishop, R J Burwood, T Doyle, D Goldsmith, G Hamilton, I Kenney, J C Kingswood, P Sharpstone (1996)
A four-year audit of interventional treatment for atheromatous renal artery stenosis.
Contrib Nephrol 119: 78-82

A Covic, D J Goldsmith, P Sambrook, M C Venning, P Ackrill (1996)
Analysis of blood pressure variability derived from ambulatory blood pressure monitoring in 92 uraemic patients.
Contrib Nephrol 119: 157-160

A Covic, I Mititiuc, D J Goldsmith, M Covic (1996)
The progression factors in autosomal dominant polycystic disease
Rev Med Chir Soc Med Nat Iasi 100: 1-2. 78-84 Jan/Jun

D J Goldsmith, A Covic, P Ackrill (1996)
Interdialysis blood pressure control by long haemodialysis sessions.
Nephrol Dial Transplant 11: 2. 401-402 Feb

A Covic, D J Goldsmith, G Georgescu, M C Venning, P Ackrill (1996)
Echocardiographic findings in long-term, long-hour hemodialysis patients.
Clin Nephrol 45: 2. 104-110 Feb

D J Goldsmith (1996)
Milk-alkali syndrome with metastatic calcification.
Am J Med 100: 4. 481-482 Apr

R M Higgins, D J Goldsmith, A MacDiarmid-Gordon, D Taberner, M C Venning, P Ackrill (1996)
Treating paracetamol overdose by charcoal haemoperfusion and long-hours high-flux dialysis.
QJM 89: 4. 297-306 Apr

D J Goldsmith, A Covic, P Sambrook, P Ackrill (1996)
Dialysis-related beta-2-microglobulin amyloidosis after long-term dialysis, and the effect of renal transplantation and cyclosporin therapy.
Am J Med 100: 5. 587-588 May

D J Goldsmith, I S Roberts, C D Short, N P Mallick (1996)
Complete clinical remission and subsequent relapse of bronchiectasis-related (AA) amyloid induced nephrotic syndrome.
Nephron 74: 3. 572-576

D J Goldsmith, A A Covic, M C Venning, P Ackrill (1996)
Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation.
Am J Kidney Dis 27: 6. 819-825 Jun

D J Goldsmith, I S Roberts, N P Mallick (1996)
Tingling extremities in a young man.
Postgrad Med J 72: 848. 380-382 Jun

D J Goldsmith (1996)
Serum ferritin concentrations in dialysis patients.
Am J Med 101: 2. 230-231 Aug

D J Goldsmith, D Sandooran, C D Short, N P Mallick, R W Johnson (1996)
Twenty-one years survival with systemic AL-amyloidosis.
Am J Kidney Dis 28: 2. 278-282 Aug

A Covic, I Mititiuc, L Caruntu, D J Goldsmith (1996)
Reversible nephrotic syndrome due to mesangiocapillary glomerulonephritis secondary to hepatic hydatid disease.
Nephrol Dial Transplant 11: 10. 2074-2076 Oct

Publications and Presentations 1995

J C Harty, D J Goldsmith, H Boulton, N Heelis, L Uttley, J Morris, M C Venning, R Gokal (1995)
Limitations of the peritoneal equilibration test in prescribing and monitoring dialysis therapy.
Nephrol Dial Transplant 10: 2. 252-257

R M Higgins, S Hearing, D J Goldsmith, B Keevil, M C Venning, P Ackrill (1995)
Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?
Postgrad Med J 71: 834. 224-226 Apr

Publications and Presentations 1994

D J Goldsmith (1994)
Does diurnal variation in blood pressure exist in CAPD patients?
Nephrol Dial Transplant 9: 11. 1698-1699

J Coyne, L al-Nakib, D Goldsmith, K O'Flynn (1994)
Secondary oxalosis and sperm granuloma of the epididymis.
J Clin Pathol 47: 5. 470-471 May

R H Mallinson, D J Goldsmith, R M Higgins, M C Venning, P Ackrill (1994)
Acute swollen legs due to rhabdomyolysis: initial management as deep vein thrombosis may lead to acute renal failure.
BMJ 309: 6965. 1361-1362 Nov

Publications and Presentations 1992

D J Goldsmith (1992)
Leukocyte intracellular pH in uraemia and diabetes.
Nephrol Dial Transplant 7: 7. 654-655

Publications and Presentations 1991

D J Goldsmith, R M Tribe, L Poston, F P Cappuccio, N D Markandu, G A MacGregor, P J Hilton (1991)
Leucocyte intracellular pH and Na(+)-H+ exchange activity in essential hypertension: an in vitro study under physiological conditions.
J Hypertens 9: 7. 645-653 Jul

Publications and Presentations 1990

D J Goldsmith, L Poston, M Watson, J Morris, P J Hilton, E J Cragoe (1990)
Effect of autologous serum on human leucocyte Na+/H+ exchange and intracellular pH.
Clin Sci (Lond) 79: 4. 357-364 Oct

Publications and Presentations 1989

N T Richards, L Poston, D J Goldsmith, E J Cragoe, P J Hilton (1989)
Endothelin-induced contraction of human peripheral resistance vessels is partly dependent on stimulation of sodium-hydrogen exchange.
J Hypertens 7: 10. 777-780 Oct